BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23998731)

  • 41. Stroma: fertile soil for inflammation.
    Patel R; Filer A; Barone F; Buckley CD
    Best Pract Res Clin Rheumatol; 2014 Aug; 28(4):565-76. PubMed ID: 25481550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging new therapies in rheumatoid arthritis: what's next for the patient?
    Leff L
    J Infus Nurs; 2006; 29(6):326-37. PubMed ID: 17122688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis.
    Lin YJ; Anzaghe M; Schülke S
    Cells; 2020 Apr; 9(4):. PubMed ID: 32260219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update on Therapeutic Approaches for Rheumatoid Arthritis.
    Nogueira E; Gomes A; Preto A; Cavaco-Paulo A
    Curr Med Chem; 2016; 23(21):2190-203. PubMed ID: 27149868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synovial tissue analysis in clinical trials.
    Bresnihan B; Baeten D; Firestein GS; Fitzgerald OM; Gerlag DM; Haringman JJ; McInnes IB; Reece RJ; Smith MD; Ulfgren AK; Veale DJ; Tak PP;
    J Rheumatol; 2005 Dec; 32(12):2481-4. PubMed ID: 16331792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pathogenesis of rheumatoid arthritis.
    Alivernini S; Firestein GS; McInnes IB
    Immunity; 2022 Dec; 55(12):2255-2270. PubMed ID: 36516818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chinese herbs as immunomodulators and potential disease-modifying antirheumatic drugs in autoimmune disorders.
    Ho LJ; Lai JH
    Curr Drug Metab; 2004 Apr; 5(2):181-92. PubMed ID: 15078195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignancy and rheumatoid arthritis: Epidemiology, risk factors and management.
    De Cock D; Hyrich K
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):869-886. PubMed ID: 31427060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Title Current Status of the Search for Biomarkers for Optimal Therapeutic Drug Selection for Patients with Rheumatoid Arthritis.
    Tsuchiya H; Fujio K
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment.
    Decker JL; Malone DG; Haraoui B; Wahl SM; Schrieber L; Klippel JH; Steinberg AD; Wilder RL
    Ann Intern Med; 1984 Dec; 101(6):810-24. PubMed ID: 6093663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Old and new therapeutics for Rheumatoid Arthritis: in vivo models and drug development.
    Sardar S; Andersson Å
    Immunopharmacol Immunotoxicol; 2016; 38(1):2-13. PubMed ID: 26769136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination therapy with DMARDs and biological agents in collagen-induced arthritis.
    Williams RO; Malfait AM; Butler DM; Walmsley MJ; Feldmann M; Maini RN
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S115-20. PubMed ID: 10589369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications.
    Zhao J; Guo S; Schrodi SJ; He D
    Front Immunol; 2021; 12():790122. PubMed ID: 34899757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunotherapy for rheumatoid arthritis.
    Taylor PC; Williams RO; Maini RN
    Curr Opin Immunol; 2001 Oct; 13(5):611-6. PubMed ID: 11544014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antifolate/antiproliferative therapy in rheumatoid arthritis.
    Cutolo M
    Clin Exp Rheumatol; 2005; 23(4):435-7. PubMed ID: 16095109
    [No Abstract]   [Full Text] [Related]  

  • 56. Perioperative Treatment of Patients with Rheumatoid Arthritis.
    Saleh KJ; Kurdi A; El-Othmani MM; Voss B; Tzeng TH; Saleh J; Lane JM; Mihalko WM
    Instr Course Lect; 2016; 65():497-508. PubMed ID: 27049215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fighting arthritis with a senescence gene.
    Carson DA; Haneji N
    Nat Med; 1999 Jul; 5(7):731-2. PubMed ID: 10395310
    [No Abstract]   [Full Text] [Related]  

  • 58. Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling.
    Manzo A; Bombardieri M; Humby F; Pitzalis C
    Immunol Rev; 2010 Jan; 233(1):267-85. PubMed ID: 20193005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment.
    Gerlag DM; Norris JM; Tak PP
    Rheumatology (Oxford); 2016 Apr; 55(4):607-14. PubMed ID: 26374913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Current trends in the therapy of rheumatoid arthritis].
    Grishina EI
    Lik Sprava; 1998 Aug; (6):18-23. PubMed ID: 9844862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.